More Recurrent monitoring of INR and prothrombin time in people getting these oral anticoagulants is recommneded, In particular within the initiation and termination of androgen therapy.[10] It is unclear if testosterone can augment the anticoagulant reaction to heparin therapy or if testosterone alters the outcome of other non-coumarin oral antico